Picano Eugenio
CNR, Institute of Clinical Physiology, Pisa, Italy.
Cardiovasc Ultrasound. 2005 May 25;3:13. doi: 10.1186/1476-7120-3-13.
Medical imaging market consists of several billion tests per year worldwide. Out of these, at least one third are cardiovascular procedures. Keeping in mind that each test represents a cost, often a risk, and a diagnostic hypothesis, we can agree that every unnecessary and unjustifiable test is one test too many. Small individual costs, risks, and wastes multiplied by billions of examinations per year represent an important population, society and environmental burden. Unfortunately, the appropriateness of cardiac imaging is extra-ordinarily low and there is little awareness in patients and physicians of differential costs, radiological doses, and long term risks of different imaging modalities. For a resting cardiac imaging test, being the average cost (not charges) of an echocardiogram equal to 1 (as a cost comparator), the cost of a CT is 3.1x, of a SPECT 3.27x, of a Cardiovascular Magnetic Resonance imaging 5.51x, of a PET 14.03x, and of a right and left heart catheterization 19.96x. For stress cardiac imaging, compared with the treadmill exercise test equal to 1 (as a cost comparator), the cost of stress echocardiography is 2.1x and of a stress SPECT scintigraphy is 5.7x. Biohazards and downstream long-term costs linked to radiation-induced oncogenesis should also be considered. The radiation exposure is absent in echo and magnetic resonance, and corresponds to 500 chest x rays for a sestamibi cardiac stress scan and to 1150 chest x rays for a thallium scan. The corresponding extra-risk in a lifetime of fatal cancer is 1 in 2000 exposed patients for a sestamibi stress and 1 in 1000 for a thallium scan. Increased awareness of economic, biologic, and environmental costs of cardiac imaging will hopefully lead to greater appropriateness, wisdom and prudence from both the prescriber and the practitioner. In this way, the sustainability of cardiac imaging will eventually improve.
全球医学影像市场每年有数十亿次检查。其中,至少三分之一是心血管检查。要知道,每次检查都意味着成本,往往还伴随着风险以及一种诊断假设,我们可以认同,每一项不必要且不合理的检查都是多余的。每年数十亿次检查中,个体的小成本、风险和浪费累积起来,就构成了对人群、社会和环境的重大负担。不幸的是,心脏成像的适宜性极低,患者和医生对不同成像方式的成本差异、放射剂量以及长期风险几乎没有认识。对于静息心脏成像检查,若将超声心动图的平均成本(非收费)设为1(作为成本比较基准),CT的成本是3.1倍,单光子发射计算机断层扫描(SPECT)是3.27倍,心血管磁共振成像(CMR)是5.51倍,正电子发射断层扫描(PET)是14.03倍,左右心导管检查是19.96倍。对于负荷心脏成像,与跑步机运动试验成本设为1(作为成本比较基准)相比,负荷超声心动图的成本是2.1倍,负荷SPECT闪烁扫描是5.7倍。还应考虑与辐射诱发肿瘤相关的生物危害和下游长期成本。超声和磁共振检查不存在辐射暴露,而心肌灌注显像心脏负荷扫描的辐射暴露相当于500次胸部X光检查,铊扫描则相当于1150次胸部X光检查。对于心肌灌注显像心脏负荷扫描,每2000名受检患者中就有1人在一生中患致命癌症的额外风险会增加;铊扫描则是每1000人中有1人。提高对心脏成像的经济、生物学和环境成本的认识,有望使开单者和从业者更加合理、明智和审慎。这样,心脏成像的可持续性最终将得到改善。